Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CARL · against 409 other Healthcare companies of similar size
Ranked #326 of 410 · scores higher than 19% of peers
Bars: peers in each 10-point band of the profitability score49 peers with a profitability score of 10–19, including CARL · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | CARL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 379 reported | -57.2% | 0.8% | 12% | 33% | |
| Operating marginHigher is better · 382 reported | -61.1% | 3.4% | 18% | 33% | |
| Return on assetsHigher is better · 408 reported | -30.7% | 0.4% | 16% | 33% | |
| Return on equityHigher is better · 387 reported | -66.1% | -0.2% | 11% | Context only | |
| Gross marginHigher is better · 428 reported | 76.6% | 38.3% | 85% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 326 | 222M GBP (≈$288M) | 17 | 13 | |
| 326 | 647M USD | 17 | 40 | |
| 326 | 593M USD | 17 | 40 | |
| 326 | 479M USD | 17 | 34 | |
| 326 | 393M USD | 17 | 50 | |
| 326 | 207M USD | 17 | 41 | |
| 326 | 255M USD | 17 | 38 | |
| 326 | 276M USD | 17 | 46 | |
| 326 | 519M USD | 17 | 22 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score